The investment is set to accelerate the company’s international expansion, product innovation and omnichannel retail presence ...

Men’s fashion brand Coolmate has raised an additional US$6 million in a funding round as it seeks to export to Southeast ...

Coolmate announced on October 30 the completion of its Series B funding round, led by Vertex Ventures Southeast Asia & India.

Vertex provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

Analyst Whitney Ijem from Canaccord Genuity maintained a Sell rating on Vertex Pharmaceuticals (VRTX – Research Report) and decreased the ...

Canaccord Genuity has maintained its Sell rating and $361.00 price target on Vertex Pharmaceuticals (NASDAQ:VRTX) Incorporated (NASDAQ: VRTX), following an investor event focused on the company's ...

Vertex's diverse pipeline positions it for a growth, despite challenges in launching new drugs like Casgevy and suzetrigine.

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Truist Financial analyst Joon Lee maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today. The company’s ...

BOSTON, October 18, 2024--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company will present its pivotal Phase 3 data on suzetrigine, an investigational, oral ...

These are the latest developments for the company. Vertex Pharmaceuticals' recent positive Phase 3 data for its non-opioid pain management drug aligns well with its market position and financial ...